These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 775550)

  • 1. Randomized controlled clinical trials in diseases of the liver.
    Chalmers TC
    Prog Liver Dis; 1976; 5():450-6. PubMed ID: 775550
    [No Abstract]   [Full Text] [Related]  

  • 2. [Randomized clinical trials in hepatology].
    Tygstrup N; Christensen E; Juhl E
    Internist (Berl); 1979 Dec; 20(12):565-70. PubMed ID: 398352
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for better clinical trials.
    Kamath PS
    Hepatology; 2008 Jul; 48(1):1-3. PubMed ID: 18571783
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical trial.
    Scheiber V; Wohlzogen FX
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):533-5. PubMed ID: 365798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The culture of designing hepato-biliary randomised trials.
    Gluud C
    J Hepatol; 2006 Mar; 44(3):607-15. PubMed ID: 16434120
    [No Abstract]   [Full Text] [Related]  

  • 6. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2583-91. PubMed ID: 16279916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Silymarin in chronic liver diseases].
    Müscher CH
    Ther Ggw; 1972 Dec; 111(12):1768-70 passim. PubMed ID: 4569030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

  • 11. Ursodeoxycholic acid in the treatment of chronic liver disease.
    Cirillo NW; Zwas FR
    Am J Gastroenterol; 1994 Sep; 89(9):1447-52. PubMed ID: 8079918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent trend in the study of liver diseases].
    Takada A
    Naika; 1970 Jan; 25(1):11-7. PubMed ID: 4908824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical treatment of acute and chronic liver diseases].
    Szabb L
    Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
    [No Abstract]   [Full Text] [Related]  

  • 14. Individual therapy-dependent prognosis based on data from controlled clinical trials in chronic liver disease.
    Christensen E
    Dan Med Bull; 1988 Apr; 35(2):167-82. PubMed ID: 3282812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of acute and chronic hepatitis. A clinical study using Inzolen infusion AM].
    Köhler FR; Ebel J
    Med Welt; 1979 Jul; 30(27):1056-60. PubMed ID: 381833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is there a therapeutic effect of cures undergone by patients with chronic liver disease? (authors transl)].
    Eberhardt G
    Leber Magen Darm; 1977 Oct; 7(5):306-9. PubMed ID: 926980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trials in HEPATOLOGY: predictors of quality.
    Kjaergard LL; Nikolova D; Gluud C
    Hepatology; 1999 Nov; 30(5):1134-8. PubMed ID: 10534332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic trials with essential phospholipids in various liver diseases].
    Alcalá-Santaella R; Fernández-Pacheco A; García García FJ; Alvarez Fernández E
    Rev Esp Enferm Apar Dig; 1972; 38(2):247-60. PubMed ID: 5073060
    [No Abstract]   [Full Text] [Related]  

  • 20. The natural history of hepatitis-associated (Australia)-antigen (HAA)-positive chronic liver disease.
    Dudley FJ; Scheuer PJ; Sherlock S
    Gut; 1972 Oct; 13(10):852. PubMed ID: 5087111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.